Clinical Trial Update: Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating L-asparaginase encapsulated in red blood cells in combination with gemcitabine or FOLFOX for second-line metastatic pancreatic adenocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• GRASPA (L-asparaginase encapsulated in red blood cells)
• Gemcitabine (Gemcitabine)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: ERYtech Pharma | Conditions: Pancreatic Adenocarcinoma Metastatic | Phase 2 | Status: COMPLETED